Coronavirus disease 2019 vaccination in patients with chronic kidney diseases.
Adverse Drug Reactions Journal
; 23(7):357-360, 2021.
Article
in Chinese
| EMBASE | ID: covidwho-2292807
ABSTRACT
Patients with chronic kidney disease (CKD) are at high risk for coronavirus disease 2019 (COVID-19). Government agencies or learned societies in many countries recommend prioritizing patients with CKD for COVID-19 vaccines. The immune response rate to the COVID-19 vaccines is lower in hemodialysis patients and kidney transplant recipients compared with that in healthy individuals, and increasing the number of vaccinations each member of these population may improve their immune response rate. There was no significant difference in the incidence of adverse reactions after vaccination between patients with CKD and healthy controls. Patients with stable CKD should be vaccinated against COVID-19 unless there were contraindications to vaccination. The mRNA vaccines, inactivated vaccines, and recombinant protein subunit vaccines are all safe for patients with CKD. Patients with CKD treated with rituximab or high-dose glucocorticoid need to weigh the benefits and risks before vaccination, and COVID-19 vaccines can be given when rituximab treatment ends for more than 6 months or after glucocorticoid reduction.Copyright © 2021 by the Chinese Medical Association.
COVID-19 vaccines; Renal insufficiency; chronic; SARS-CoV-2; Vaccination; article; chronic kidney failure; coronavirus disease 2019/dt [Drug Therapy]; coronavirus disease 2019/pc [Prevention]; drug contraindication; drug megadose; hemodialysis; hemodialysis patient; high risk patient; human; immune response; infection prevention; kidney graft; priority journal; recipient; glucocorticoid/do [Drug Dose]; inactivated vaccine; recombinant vaccine; rituximab; RNA vaccine; SARS-CoV-2 vaccine/dt [Drug Therapy]; subunit vaccine
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Topics:
Vaccines
Language:
Chinese
Journal:
Adverse Drug Reactions Journal
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS